Uptake of chemically modified antagomirs by lung relevant cell systems

Authors

Anna Rydzik, AstraZeneca, SwedenFollow
Julie Weidner, AstraZeneca, Sweden
Werngard Czechtizky, AstraZeneca, Sweden
Henric Olsson, AstraZeneca, Sweden
Felix Gnerlich, AstraZeneca, Sweden
Stefan Vollmer, AstraZeneca, Sweden
Marion Garreau, AstraZeneca, Sweden
Elisabeth Ax, AstraZeneca, Sweden
Reetta Holmila, AstraZeneca, Sweden
Ewa Kolosionek, AstraZeneca, Sweden

Conference Dates

April 4 - 8, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Anna Rydzik, Julie Weidner, Werngard Czechtizky, Henric Olsson, Felix Gnerlich, Stefan Vollmer, Marion Garreau, Elisabeth Ax, Reetta Holmila, and Ewa Kolosionek, "Uptake of chemically modified antagomirs by lung relevant cell systems" in "Delivery Of Nucleic Acid Therapeutics II: Biology, Engineering And Development", Steven F. Dowdy, UCSD School of Medicine, USA; Laura Sepp-Lorenzino, Intellia Therapeutics, USA; Matt Stanton, Generation Bio, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/nucleic_acid_therapeutics_ii/5